Assessing prognosis of acute coronary syndrome in recent clinical trials: A systematic review.

15Citations
Citations of this article
134Readers
Mendeley users who have this article in their library.

Abstract

There is no recent comprehensive overview of contemporary clinical trials assessing short and long-term outcomes in patients with acute coronary syndrome (ACS). This paper reviews factors from recent clinical trials that influenced prognosis in patients with ACS. Cochrane and PubMed databases were screened systematically for clinical trials published in the English literature reporting on ACS prognosis. Two authors independently screened titles, abstracts, and full text. Studies meeting inclusion criteria evaluated the impact of modern practice on prognosis. In vitro and animal models studies, conference abstracts, imaging studies, and review articles were excluded. Disagreement in inclusion criteria was resolved by consensus. A large study of 8,859 patients showed no difference in all-cause mortality between 31 days and 2 years in patients with ST segment elevation myocardial infarction (STEMI) compared to those with non-ST segment elevation myocardial infarction (NSTEMI) or stable ischemic heart disease (SIHD). Other studies showed a significant increase in all-cause mortality in patients with STEMI within the first 30 days, with NSTEMI patients exhibiting a higher mortality rate compared to those with SIHD during the 2-year follow-up period. Our review found that women have a poorer short-term prognosis compared to men. Additionally, reports from patients receiving comprehensive and coordinated care showed longer survival rates. In view of the improved prognosis demonstrated for patients suffering from ACS, assessing prognosis in patients represents a formidable task in modern practice. Our review highlights the need for further evidence-based studies evaluating long-term outcomes on diagnostic and treatment strategies.

References Powered by Scopus

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC)

5076Citations
N/AReaders
Get full text

2013 ESC guidelines on the management of stable coronary artery disease

4158Citations
N/AReaders
Get full text

A prospective natural-history study of coronary atherosclerosis

2729Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Correlation between exercise, personal income level and health-related quality of life in patients with newly diagnosed stable angina

8Citations
N/AReaders
Get full text

Care coordination across healthcare systems: development of a research agenda, implications for practice, and recommendations for policy based on a modified Delphi panel

7Citations
N/AReaders
Get full text

Working group on myocardial markers (GdS MM) of the Italian society of clinical pathology and laboratory medicine (SIPMeL). Recommendation for the use of myocardial markers in NSTEMI. Third part: Prognosis and risk stratification

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ye, F., Winchester, D., Jansen, M., Lee, A., Silverstein, B., Stalvey, C., … Yale, S. H. (2019, June 1). Assessing prognosis of acute coronary syndrome in recent clinical trials: A systematic review. Clinical Medicine and Research. Marshfield Clinic. https://doi.org/10.3121/cmr.2019.1433

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 25

83%

Professor / Associate Prof. 2

7%

Researcher 2

7%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 33

72%

Nursing and Health Professions 7

15%

Neuroscience 3

7%

Psychology 3

7%

Save time finding and organizing research with Mendeley

Sign up for free